Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.

Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...

Полное описание

Библиографические подробности

Опубликовано в::	J Clin Pathol
Главные авторы:	Aukland, A, Hurlow, R A, George, A J, Stuart, J
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMJ Publishing Group 1982
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC497768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7047575/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.35.7.740
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!